Therapeutic opportunities for targeted liposomal drug delivery
Authors:
- Theresa M. AllenTATheresa M. Allen
- Elaine H. MoaseEMElaine H. Moase
- 1 September 1996
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 21 (2) , 117-133
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Design of immunoliposomes directed against human ovarian carcinomaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Adhesion molecules: a new target for immunoliposome‐mediated drug deliveryFEBS Letters, 1995
- Long circulating, cationic liposomes containing amino‐PEG‐phosphatidylethanolamineFEBS Letters, 1994
- Long-Circulating Liposomes: Development and PerspectivesJournal of Liposome Research, 1992
- Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Letters, 1991
- Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes.Chemical and Pharmaceutical Bulletin, 1991
- Tumour targeting with antibody-coupled liposomes: Failure to achieve accumulation in xenografts and spontaneous liver metastasesCancer Immunology, Immunotherapy, 1990
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990
- Protein immobilization on the surface of liposomes via carbodiimide activation in the presence of N‐hydroxysulfosuccinimideFEBS Letters, 1988